Mankind Pharma (MANKIND) Share Price Rises 2.8% to Rs 2,507.95
- September 29, 2026
- Posted by: Kunal Singla
- Category: News
Mankind Pharma Share Price is rising today after the stock moved to Rs 2,507.95, up 2.8% from the previous close, with market capitalisation at Rs 1,02,247.25 crore. The move places Mankind Pharma in focus across Mankind Pharma Share Price Today searches, Mankind Pharma Stock News and Mankind Pharma Share Price News as investors track the intraday price rise. The price move is confirmed in Univest data; a company-specific reason has not been established. The latest Univest figures show that the stock is trading near its day high, which makes the price action relevant even without a stated trigger. For readers following Mankind Pharma Share Price Live, the next useful lens is the company’s valuation and sector standing, because that is where the clearest context for today’s share price gain sits. Univest data helps place the move in the right frame.
Mankind Pharma Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 2,507.95 |
| Previous Close | Rs 2,439.55 |
| Today's Move | Rs 68.4 (+2.8%) |
| Open | Rs 2,439.55 |
| High | Rs 2,509.9 |
| Low | Rs 2,439.55 |
| Market Capitalisation | Rs 1,02,247.25 crore |
| Market Cap Category | Large Cap |
Mankind Pharma Ltd. (MANKIND) rose to Rs 2,507.95 from the previous close of Rs 2,439.55, a move of Rs 68.4 or 2.8%. The stock opened at Rs 2,439.55, reached a high of Rs 2,509.9, recorded a low of Rs 2,439.55.
Mankind Pharma Share Price Today shows a firm intraday price rise. The stock opened at Rs 2,439.55, matched the previous close, then moved to Rs 2,509.90 at the day high and Rs 2,439.55 at the day low before last trading at Rs 2,507.95. That leaves Mankind Pharma Share Price up by Rs 68.40, or 2.8%, as of 29 September 2026 at 11:07:59 AM IST. The current move also puts the stock just below the intraday high, which is useful for reading Mankind Pharma Share Price Update commentary without adding anything beyond the numbers. For investors following Mankind Pharma Stock Performance, the day’s pattern is simple: a higher quote, a wider intraday range and a market cap above Rs 1 lakh crore. That takes the discussion naturally toward Mankind Pharma Fundamental Analysis.
Mankind Pharma Ltd. (MANKIND) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 1,02,247.25 crore |
| P/E Ratio | 49.33x |
| P/B Ratio | 5.99x |
| ROE | 12.69% |
| ROCE | 13.24% |
| EPS | Rs 49.45 |
| Book Value Per Share | Rs 407.39 |
| Dividend Yield | 0.04% |
Mankind Pharma Ltd. (MANKIND) fundamental metrics show P/E 49.33x, P/B 5.99x, ROE 12.69%, ROCE 13.24%. These ratios show where the company stands today and are not a call to buy or sell.
Mankind Pharma Ltd. has a market capitalisation of Rs 1,02,247.25 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 49.33x, P/B at 5.99x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 12.69% and ROCE of 13.24%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 49.45, book value per share of Rs 407.39, dividend yield of 0.04%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 32.59x, median ROE of 11.7%, median ROCE of 13.61%. Together they describe the fundamental backdrop without implying a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 49.33x |
| Benchmark Median P/E | 32.59x |
| Benchmark Average P/E | 49x |
| Benchmark P/E Range | 3.46x to 707.31x |
| Company P/B Ratio | 5.99x |
| Benchmark Median P/B | 2.88x |
| Company ROE | 12.69% |
| Benchmark Median ROE | 11.7% |
| Company ROCE | 13.24% |
| Benchmark Median ROCE | 13.61% |
| Company Market Capitalisation | Rs 1,02,247.25 crore |
| Benchmark Median Market Cap | Rs 783.26 crore |
Mankind Pharma Ltd. (MANKIND) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.
Mankind Pharma Ltd. (MANKIND) has a P/E ratio of 49.33x, which is above the benchmark median of 32.59x, a difference of +51.37%. A P/E difference of this kind is a reference point rather than a recommendation.
Mankind Pharma Ltd. (MANKIND) has a ROE of 12.69%, which is above the benchmark median of 11.7%, a difference of +8.46%. Mankind Pharma Ltd. (MANKIND) has a ROCE of 13.24%, which is below the benchmark median of 13.61%, a difference of -2.72%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,44,716.74 | 36.5 | 5.1 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,55,115.31 | 86.51 | 14.33 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,89,613.38 | 84.92 | 20.64 | 26.76 | 19.27 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,19,899.96 | 26.79 | 4.48 | 19.69 | 21.39 |
| Cipla Ltd. | CIPLA | 1,12,875.68 | 33.29 | 3.19 | 11.83 | 16 |
Mankind Pharma Ltd. (MANKIND) has a P/E ratio of 49.33x compared with the displayed peer median of 36.5x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 12.69% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 13.24% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Mankind Pharma Ltd. (MANKIND) has a market capitalisation of Rs 1,02,247.25 crore. All 5 peers shown have a larger market capitalisation.
Why Investors Are Watching Mankind Pharma
- Mankind Pharma Share Price is trading 2.8% higher, so the intraday price rise itself is the first reason it is in focus.
- Mankind Pharma Share Price Today is near the day high, which makes the price action worth tracking in real time.
- The valuation profile, including P/E of 49.33 and P/B of 5.99, gives Mankind Pharma Stock News a clear fundamental angle.
- ROE of 12.69% and ROCE of 13.24% help explain why Mankind Pharma Stock Analysis remains relevant.
- The healthcare sector benchmark and peer set give Mankind Pharma Share Price a useful comparison frame.
About Mankind Pharma
Mankind Pharma Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. Mankind Pharma Share Price reflects a business that sits among India’s prominent listed pharma names by market capitalisation. The company is tracked on both NSE and BSE, and its scale is visible in the market capitalisation of Rs 1,02,247.25 crore. In company overview terms, the stock belongs to a sector where valuation, earnings quality and capital efficiency matter closely. Mankind Pharma Share Price therefore needs to be read alongside its P/E, P/B, ROE, ROCE, EPS and book value rather than only as a one-day move. For Mankind Pharma Stock News readers, the key business context is simple: this is a large healthcare franchise whose market worth and profitability ratios place it in active competition with other major pharmaceutical names. Univest data keeps the company profile anchored to measurable facts.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why is Mankind Pharma Share Price rising today?
Ans. Mankind Pharma Share Price is higher by 2.8% today, and the move is confirmed by Univest data. No company-specific catalyst is established, so the focus stays on the verified price action and valuation context.
What is Mankind Pharma Share Price Today?
Ans. Mankind Pharma Share Price Today is Rs 2,507.95. The stock is up Rs 68.40 from the previous close and is trading close to the day high, which keeps the intraday move in focus.
How does Mankind Pharma compare on valuation?
Ans. Mankind Pharma Share Price carries a P/E of 49.33 and a P/B of 5.99. Compared with the industry median P/E of 32.59, the stock is valued above the mid-point of the benchmark set.
What do ROE and ROCE say about Mankind Pharma?
Ans. Mankind Pharma Share Price is supported by ROE of 12.69% and ROCE of 13.24%. ROE is above the industry median, while ROCE sits close to the sector benchmark, giving useful operating context.
What are the EPS and book value for Mankind Pharma?
Ans. Mankind Pharma has EPS of 49.45 and book value of Rs 407.39. These figures help explain the base behind Mankind Pharma Share Price and show the earnings and accounting value per share.
How does Mankind Pharma compare with peers?
Ans. Mankind Pharma Share Price sits below premium peers such as Divi’s Laboratories and Torrent Pharmaceuticals on P/E, while staying above Zydus Lifesciences and Cipla. Its ROE is also below several top peers.
Should investors track Mankind Pharma Share Price on Univest?
Ans. Yes. Mankind Pharma Share Price on Univest can be tracked with live price, market cap, valuation ratios and sector context. That makes it easier to follow price action alongside fundamentals and peers.
Track Mankind Pharma Share Price on Univest
Use Mankind Pharma Ltd. (MANKIND) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Track Mankind Pharma Share Price on Univest for live share price, market cap, valuation ratios, 52-week levels and company insights in one place. Mankind Pharma Share Price Today can be followed alongside fundamental analysis, sector comparison and peer performance, helping readers monitor the stock’s next move with verified context. Univest also presents Mankind Pharma Stock News in a format designed for quick reading and deeper study.
